NSEShareholders meeting2d ago · 3 Sept 2026, 09:27 pm

Shareholders meeting

Laxmi Dental Limited · LAXMIDENTL

✦ AI Summaryshareholders_meeting

Laxmi Dental Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2026, to transact Ordinary and Special Business.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Laxmi Dental Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2026

Attachments (1)

📄

LAXMI_03092026212633_Intimation_of_22nd_AGM.pdf

pdf

Download →
View document text
Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058. Tel: 022 61437991 | Email: info@laxmidentallimited.com | Website: www.laxmidentallimited.com CIN No: L51507MH2004PLC147394 | GST No: 27AABCL0001A1ZL Date: September 03, 2026 Listing Department Listing & Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Mumbai – 400001 Plot No. C/1, “G” Block BSE Scrip Code: 544339 Bandra-Kurla Complex Bandra (E), Mumbai – 400 051 Symbol: LAXMIDENTL Re: LAXMI DENTAL LIMITED - ISIN: INE0WO601020 Dear Sir(s)/Madam(s), Sub: Intimation of 22nd Annual General Meeting (“AGM”) scheduled to be held on Friday, September 25, 2026 With reference to the above captioned subject, please find enclosed herewith Notice of the 22nd Annual General Meeting (AGM) of Laxmi Dental Limited (“the Company”), scheduled to be held on Friday, September 25, 2026 at 10:00 am (IST) through video conferencing / other audio-visual means (VC/OAVM), to transact the Ordinary and Special Business as set out in the enclosed Notice convening the AGM of the Company. The said Notice is uploaded on the Company’s website at: https://laxmidentallimited.com/public/investors/shareholding_meeting/Notice%20of%2022n d%20AGM.pdf This is for your kind information and records. For Laxmi Dental Limited --------------------------------------------------- Suman Saha Company Secretary and Compliance Officer Membership Number: A33035 Encl.: As above. 2025-26 1 Annual Report Notice Notice is hereby given that the 22nd (Twenty Second) Annual SPECIAL BUSINESS: General Meeting (“AGM”) of the members of Laxmi Dental 4. To approve variation in the objects/terms of utilisation Limited (“the Company”) will be held on Friday, 25 September, of the Initial Public Offering (“IPO”) proceeds and 2026 at 10:00 a.m. (IST) through Video Conferencing (“VC”)/ extension of the timeline for utilisation of IPO Proceeds. Other Audio Video Means (“OAVM”) to transact the following To consider and, if thought fit, to pass the following businesses: resolution as a Special Resolution: ORDINARY BUSINESS: “RESOLVED THAT pursuant to the provisions of Section 1. To receive, consider and adopt the audited standalone 13(8) and 27 of the Companies Act, 2013 (the “Act”), and financial statements of the Company for the financial other applicable provisions, if any, of the Act read with year ended 31 March, 2026, including the Audited Rule 32 of the Companies (Incorporation) Rules, 2014 Balance Sheet as on that date, the Statement of Profit and Rule 7 of the Companies (Prospectus and Allotment and Loss and Cash Flow Statement for the financial of Securities) Rules, 2014, applicable provisions of the year ended on that date together with the Reports of SEBI (Listing Obligations and Disclosure Requirements) the Board of Directors and Auditors thereon. Regulations, 2015 and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (“SEBI 2. To receive, consider and adopt the audited consolidated ICDR Regulations”) (including any statutory modification financial statements of the Company for the financial or re-enactment thereof) and other applicable rules, year ended 31 March, 2026, including the Audited regulations, guidelines and other statutory provisions Balance Sheet as on that date, the Statement of Profit for the time being in force, and subject to any other and Loss and Cash Flow Statement for the financial applicable approvals, permissions and/or sanctions, year ended on that date together with the Reports of the consent of the shareholders of the Company be and the Auditors thereon. is hereby accorded for the variation in the objects of 3. To re-appoint Mr. Rajesh Vrajlal Khakhar the spending of Initial Public Offering (IPO) proceeds (DIN: 00679903), Whole-time Director, as a Director (“IPO Proceeds”) and extension of the timeline for liable to retire by rotation and, being eligible, offers the utilisation of the IPO Proceeds, as stated in the himself for re-appointment. Prospectus dated 16 January, 2025 (“Prospectus”) filed by the Company with the Stock Exchanges, Registrar of Companies (“RoC”) and the Securities and Exchange Board of India (“SEBI”). (in INR million) Sr. Objects of the IPO Total Money Extent of Amount Details of Revised Balance Revised No. amount utilised achievement unutilised variation amount after post timeline raised for the as on 18 Proposed Proposed for object August, 2026 Variation Variation utilisation Original objects of the IPO as stated in the Prospectus 1. Repayment/prepayment, in full 229.84 229.84 100% - No change - - - or in part, of certain outstanding borrowings availed by our Company 2. Investment in certain Subsidiaries 46.00 46.00 100% - No change - - - for the repayment/prepayment, in full or in part, of certain outstanding borrowings 3. Funding the capital expenditure 435.07 177.81 40.87% 257.26 Funds NIL NIL - requirements for purchase of new reallocated machinery for our Company to newly added object 4. *Investment in our Subsidiary, 250.04 26.27 10.51% 223.77 Funds NIL NIL - Bizdent Devices Private Limited, reallocate for the capital expenditure d to newly requirements for the purchase of added new machinery object Notice Notice (Contd.) (in INR million) Sr. Objects of the IPO Total Money Extent of Amount Details of Revised Balance Revised No. amount utilised achievement unutilised variation amount after post timeline raised for the as on 18 Proposed Proposed for object August, 2026 Variation Variation utilisation 5. General Corporate purposes 320.75 320.75 100% - No change - - - Total (1 to 5) 1,281.70 800.67 - 481.03 New Object 6. **Acquisition of Land and - - - - Addition 268.96 268.96 Financial Construction of Building and Year infrastructure for manufacturing 2027 and plant for dental laboratory and dental Financial aligner facility Year 2028 7. **Purchase of movable assets - - - - Addition 212.07 212.07 Financial including machinery, computer and Year computer equipment, furniture & 2027 and fixtures, office equipment for the Financial existing and/or newly constructed Year 2028 facility Total (6 to 7) - - - - 481.03 481.03 *As per the Objects of the Offer, an amount of INR 250.04 million was earmarked towards investment in the Company’s Subsidiary, Bizdent Devices Private Limited (“BDPL”), for capital expenditure requirements towards the purchase of new machinery. Of the aforesaid amount, INR 26.27 million is already utilised and the remaining INR 223.77 million is unutilised as on 18 August, 2026. The Board of Directors, vide its intimation letter dated 26 March, 2026, has approved the merger of the BDPL with the Company, which is currently pending approval of the Regional Director. Upon the Merger becoming effective, BDPL shall stand amalgamated into the Company. In view of the foregoing the said amount shall continue to be utilised by BDPL for the purposes specified under Object No. 6 and Object No. 7 until effective date and upon the Merger becoming effective, the balance amount of IPO proceeds shall continue to be utilised directly by the Company for the purposes specified under Object No. 6 and Object No. 7. Accordingly, the aforesaid amount is proposed to be reallocated for the new object as stated. **The revised timelines for utilisation indicated above in relation to Object No. 6 and Object No. 7, are based on the current business requirements and assumptions of the Company and are subject to, inter alia, identification and finalisation of suitable movable assets, completion of due diligence of land, execution of definitive agreements, receipt of requisite statutory, regulatory and contractual approvals related to land, timely fulfilment of conditions precedent, and prevailing market conditions. Accordingly, depending upon the occurrence of the aforesaid factors and other unforeseen circumstances, the actu [Showing first 8,000 characters — download PDF for full document]